icodextrin and maltotetraose

icodextrin has been researched along with maltotetraose* in 3 studies

Trials

1 trial(s) available for icodextrin and maltotetraose

ArticleYear
Clinical experience with icodextrin in children: ultrafiltration profiles and metabolism.
    Pediatric nephrology (Berlin, Germany), 2000, Volume: 15, Issue:1-2

    Icodextrin use in adults provides sustained ultrafiltration (UF) in long-term dwells. No information is available on UF and metabolism in children. In 11 children, a volume of 1,049+/-138 ml/m2 of the study fluid (1.36% glucose, 7.5% icodextrin, 3.86% glucose) was administered for 12 h. Net UF with icodextrin (339+/-147 ml/1.73 m2) did not differ from UF with 3.86% glucose (450+/-306 ml/1.73 m2, P=0.53) and was higher than UF with 1.36% glucose (-87+/-239 ml/1.73 m2, P=0.003). Icodextrin added 0.52+/-0.07 to the weekly Kt/V. Over 6 weeks, icodextrin was used for 12-h daytime dwell. Total icodextrin reached a steady-state level of 2.91+/-1.22 g/l at 2 weeks. The main icodextrin metabolites were maltose, maltotriose, and maltotetraose. After 2 weeks, steady state levels were 2.02+/-0.66 mmol/l, 1.46+/-0.35 mmol/l, and 0.45+/-0.12 mmol/l. No icodextrin or metabolites were detectable 4 weeks after the study. We conclude that 7.5% icodextrin is capable of maintaining UF during 12-h dwell in children and is comparable to UF obtained with 3.86% glucose. Steady-state levels of icodextrin and metabolites were reached at 2 weeks and disappeared after the study.

    Topics: Adolescent; Adult; Blood Glucose; Child; Child, Preschool; Dialysis Solutions; Female; Glucans; Glucose; Humans; Icodextrin; Male; Maltose; Oligosaccharides; Peritoneal Dialysis; Ultrafiltration

2000

Other Studies

2 other study(ies) available for icodextrin and maltotetraose

ArticleYear
Lack of interference of icodextrin on creatinine measurements.
    Advances in peritoneal dialysis. Conference on Peritoneal Dialysis, 1999, Volume: 15

    Glucose has been reported to interfere in the analysis of creatinine by the Jaffe method. The potential interference of icodextrin and its primary metabolites (maltose, maltotriose, maltotetraose) on creatinine measurements has not previously been addressed. We evaluated the potential interference of icodextrin and its metabolites at various concentrations using both the Jaffe and Creatinine Plus methods. Interference was determined in samples containing 0.6-20 mg/dL creatinine in saline solution or in plasma (n = 6), and in dialysate samples (n = 6) spiked with icodextrin, maltose, maltotriose, and maltotetraose at concentrations up to twofold the level found in plasma and dialysate from patients treated using icodextrin. Results confirm that no interference occurs when using either the colorimetric Jaffe method or the enzymatic Creatinine Plus method at levels up to 65 g/L icodextrin, 2 g/L maltose, 2 g/L maltotriose, and 1 g/L maltotetraose, levels representing worst-case clinical concentrations. In addition, our results confirm that comparable values can be obtained using either the Jaffe or the Creatinine Plus method for the analysis of creatinine in uremic plasma and in dialysate samples.

    Topics: Creatinine; Dialysis Solutions; Glucans; Glucose; Humans; Icodextrin; Maltose; Oligosaccharides; Trisaccharides; Ultrafiltration

1999
Positive interference of icodextrin metabolites in some enzymatic glucose methods.
    Clinical chemistry, 1998, Volume: 44, Issue:11

    Topics: Blood Glucose; Dialysis Solutions; Glucans; Glucose; Glucose 1-Dehydrogenase; Glucose Dehydrogenases; Glucose Oxidase; Humans; Icodextrin; Maltose; Oligosaccharides; Trisaccharides

1998